Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.

Our Experts

Stephane Budel

Miguel Edwards

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Life Science Tools & Manufacturing

Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform

A leader in research tools and clinical diagnostic development asked DeciBio to evaluate the opportunity for an ultra-sensitive detection platform in methylation analysis

Target Identification

IVDR Opportunity Assessment

A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product

Voice-of-Customer Research

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to the recent approval of a competing cancer therapy in earlier lines of treatment

Competitive Analysis

Voice-of-Customer Research

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help